The biological threshold where a growth becomes a life-threatening threat
In short: Not all tumors are created equal. While some are localized and slow-moving, others possess the biological machinery to hijack the body's systems. Understanding the transition from a simple growth to invasive cancer requires looking at how cells break their boundaries and demand new resources.
In pathology, tumors are categorized as either benign or malignant. Benign tumors are composed of cells that remain relatively similar to normal cells. They generally grow slowly and stay contained within a covering of normal cells. They typically only become problematic if they grow large enough to press on organs, cause pain, or release hormones that disrupt bodily functions. In contrast, malignant tumors are made of cancer cells that divide rapidly and have the ability to invade surrounding tissues.
A critical distinction in oncology is the breach of the basement membrane. All body tissues have a protective layer called the basement membrane that keeps cells contained. When cancer cells remain within their tissue of origin, it is called carcinoma in situ. However, once these cells break through that membrane, the cancer is classified as invasive. This transition allows the cancer to enter the bloodstream or the lymph system, where it can travel to distant sites to form secondary tumors, a process known as metastasis.
To sustain rapid growth, a tumor must overcome a physical limitation: the distance from blood vessels. As a tumor expands, its center becomes starved of oxygen and nutrients. To survive, cancer cells release signals called angiogenic factors. These factors trigger angiogenesis, the process of stimulating the growth of hundreds of new capillaries into the tumor. While anti-angiogenic drugs can block this process to shrink a tumor, they cannot eliminate the cancer entirely, highlighting the complex interplay between cellular growth and the body's circulatory infrastructure.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Introduction to Oncology - Tumors - Benign vs. Malignant (Cancer) - Pathology
- Also: Benign and malignant tumours | Carcinoma in situ | Cancer growth | Cancer Research UK
To cite this card, link to https://intellectplus.co.uk/app/science-introduction-to-oncology-tumors-benign-vs-malignant-cancer-p.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Biology · More in Science · Latest · A–Z · All topics
